719 related articles for article (PubMed ID: 16831363)
21. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium.
Mylonas I; Makovitzky J; Friese K; Jeschke U
Acta Histochem; 2009; 111(4):349-59. PubMed ID: 19195687
[TBL] [Abstract][Full Text] [Related]
22. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium.
Snijders MP; de Goeij AF; Koudstaal J; Thunnissen EB; de Haan J; Bosman FT
J Pathol; 1992 Feb; 166(2):171-7. PubMed ID: 1560318
[TBL] [Abstract][Full Text] [Related]
23. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
[TBL] [Abstract][Full Text] [Related]
24. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
[TBL] [Abstract][Full Text] [Related]
26. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
29. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
30. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
31. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
33. Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters.
Kitaoka Y; Kitawaki J; Koshiba H; Inoue S; Ishihara H; Teramoto M; Honjo H
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):183-9. PubMed ID: 15084350
[TBL] [Abstract][Full Text] [Related]
34. The immunohistochemical evaluation of estrogen receptor-alpha and progesterone receptors of normal, hyperplastic, and neoplastic endometrium in 88 pet rabbits.
Asakawa MG; Goldschmidt MH; Une Y; Nomura Y
Vet Pathol; 2008 Mar; 45(2):217-25. PubMed ID: 18424838
[TBL] [Abstract][Full Text] [Related]
35. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
39. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
40. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
Wang X; Huang Z; Di W; Lin Q
Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
